Appco Company Profile
✉ Email this page to a colleague
What is the competitive landscape for APPCO, and what generic and branded alternatives to APPCO drugs are available?
APPCO has eighteen approved drugs.
Summary for Appco
| US Patents: | 0 |
| Tradenames: | 18 |
| Ingredients: | 18 |
| NDAs: | 18 |
Drugs and US Patents for Appco
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Appco | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | CAPSULE;ORAL | 211893-002 | Apr 5, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Appco | PERPHENAZINE | perphenazine | TABLET;ORAL | 210163-004 | May 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Appco | PERPHENAZINE | perphenazine | TABLET;ORAL | 210163-003 | May 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Appco | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | CAPSULE;ORAL | 211893-001 | Apr 5, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
